Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
schizophrenia
Biotech
Karuna CEO says biotech can launch drugs too, amid deal rumors
Karuna is 24 months out from a major drug launch and the industry is buzzing with rumors that the biotech will seek a deal for commercialization.
Annalee Armstrong
Jan 10, 2023 1:21pm
Karuna executive departs in lead up to pivotal drug launch
Jan 6, 2023 12:43pm
Safety data for Cerevel's schizophrenia drug de-risks asset
Dec 20, 2022 10:36am
Autoreceptor absence fuels dopamine dysfunction in schizophrenia
Nov 1, 2022 11:00am
Merck gains Moderna's cancer shot, signs Royalty collab
Oct 12, 2022 10:55am
Karuna hits goal in schizophrenia phase 3, teeing up 2023 filing
Aug 8, 2022 9:48am